{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:53:05Z","timestamp":1718869985849},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.contraception.2005.09.014","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T12:14:39Z","timestamp":1133352879000},"page":"344-347","source":"Crossref","is-referenced-by-count":15,"title":["Effects of two different oral contraceptives on total body water: a randomized study"],"prefix":"10.1016","volume":"73","author":[{"given":"Rog\u00e9rio Bonassi","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio","family":"Tachotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauce","family":"Cavenague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.09.014_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin\u2013aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"issue":"Suppl 3","key":"10.1016\/j.contraception.2005.09.014_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14730782.2000.12288986","article-title":"Drospirenone\u2014a new progestogen with antimineralocorticoid activity, resembling natural progesterone","volume":"5","author":"Oelkers","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.09.014_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem-43-5-1036","article-title":"Effects of ethinylestradiol on the renin\u2013angiotensin\u2013aldosterone-system and on plasma transcortin in women and men","volume":"43","author":"Oelkers","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.014_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000441-197807000-00004","article-title":"Estrogens and hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin\u2013aldosterone system","volume":"276","author":"Crane","year":"1978","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.contraception.2005.09.014_bib5","first-page":"67","article-title":"Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate","volume":"36","author":"Skinner","year":"1969","journal-title":"Clin Sci"},{"key":"10.1016\/j.contraception.2005.09.014_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/713604397","article-title":"Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms","volume":"8","author":"Apter","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.09.014_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin\u2013angiotensin\u2013aldosterone system in healthy female volunteers","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2005.09.014_bib8","first-page":"195","article-title":"Effects of oral contraceptives on the renin\u2013aldosterone system: overview and report on a new natriuretic progestogen","volume":"7","author":"Oelkers","year":"1991","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2005.09.014_bib9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.014_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin\u2013aldosterone system in normal women","volume":"73","author":"Oelkers","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2005.09.014_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.201.12.918","article-title":"Oral contraceptives. Renin, aldosterone, and high blood pressure","volume":"201","author":"Laragh","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2005.09.014_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(95)00191-C","article-title":"A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 \u03bcg ethinylestradiol\/75 \u03bcg gestodene and 20 \u03bcg ethinylestradiol\/150 \u03bcg desogestrel, with respect to efficacy, cycle control and tolerance","volume":"52","author":"Endrikat","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-7824(01)00213-X","article-title":"A 12-month clinical investigation with a 24-day regimen containing 15 \u03bcg ethinylestradiol plus 60 \u03bcg gestodene with respect to hemostasis and cycle control","volume":"63","author":"Fruzzetti","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2004.09.005","article-title":"Twenty micrograms vs >20 \u03bcg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials","volume":"71","author":"Gallo","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.contraception.2003.10.016","article-title":"A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet\u00ae (gestodene75\/EE20) on body fat","volume":"70","author":"de Melo","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0025-7125(16)30011-6","article-title":"A clinician's guide to the premenstrual syndrome","volume":"79","author":"Barnhart","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.contraception.2005.09.014_bib18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1681\/ASN.V1051067","article-title":"Body composition in renal transplant patients: bioimpedance analysis compared to isotope dilution, dual energy X-ray absorptiometry, and anthropometry","volume":"10","author":"van den Ham","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2005.09.014_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(94)00003-F","article-title":"Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays","volume":"51","author":"Fuhrmann","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.014_bib20","first-page":"69","article-title":"Evaluation of body composition during low-dose estrogen oral contraceptives treatment","volume":"26","author":"Franchini","year":"1995","journal-title":"Acta Eur Fertil"},{"key":"10.1016\/j.contraception.2005.09.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1078\/0018-442X-00035","article-title":"Influence of various factors on the measurement of multifrequency bioimpedance","volume":"53","author":"Gualdi-Russo","year":"2002","journal-title":"J Comp Hum Biol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240500394X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240500394X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T06:05:33Z","timestamp":1706767533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078240500394X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S001078240500394X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.09.014","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}